Hesperetin has been shown a potential drug for acute lung injury (ALI) induced in vivo by lipopolysaccharide by downregulated the Toll-like receptor 4 (TLR4) and suppressed NF-κB activation in lung tissue [154]. This evidence concerns the gene TLR4 and acute respiratory distress syndrome.